Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis

Recent advances in our understanding of the role of interleukin (IL)-6 in autoimmunity and in particular rheumatoid arthritis (RA) have brought about important changes in the way we think about autoimmune diseases. Encouraging data from several phase III clinical trials of tocilizumab, a humanized m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hushaw, Linda L, Sawaqed, Ray, Sweis, Ghaleb, Reigle, Jori, Gopal, Anjali, Brandt, Daniel, Sweis, Nadia, Curran, James, Niewold, Timothy B, Sweiss, Nadera J
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2010
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2857613/
https://ncbi.nlm.nih.gov/pubmed/20421913
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars